Standard of Care for mRCC May Change
Data support first-line treatment with combined regimens that include an immunotherapeutic agent
Diagnosis & Disease Information
That Nebulous Concept Called Standard of Care
During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…
Periodontal Disease Care in CKD Cuts Cardiovascular Risks
The presence of periodontal disease in chronic kidney disease significantly increased the risk of all-cause, but not cardiovascular, mortality.
TRT Reduces Post-RARP Recurrence Risk in Low-Risk Prostate Cancer
Testosterone replacement therapy prolonged time to disease progression among men who underwent radical surgery for localized prostate cancer.
Unique Drug Cuts CRPC Mets Risk
SAN FRANCISCO—Darolutamide, a structurally unique androgen receptor antagonist, prolongs metastasis-free survival (MFS) and decreases the risk of pain progression in men with nonmetastatic castration-resistant prostate cancer (nmCRPC), without adversely affecting quality of life, according to study findings presented at the 2019 Genitourinary Cancers Symposium and published concurrently in The New England Journal of Medicine. “This…
Continuous Learning: Lessons From a Right-Handed Mouse
Inadequate technology can be barriers to physicians fulfilling their continuing medical education obligation.
Better Communication Cuts Down on Surgery-Related Deaths
South Carolina hospitals use a checklist to increase safety in the operating room. As part of a novel program, 14 hospitals in South Carolina reduced post-surgery mortality rates by 22% through the simple act of using a checklist in their operating rooms. The hospitals, which account for almost 40% of the state’s inpatient surgeries, completed…
Study: ESA Use Prior to Dialysis Transition Does Not Improve Outcomes
Study finds no decrease in the risk for mortality, myocardial infarction, or heart failure in the first 180 days.
Improving Dialysis for Undocumented Immigrants With ESRD
Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.
- Loading...
Loading...
Next post in Hemodialysis
Loading... 
Loading...